ArticleCancer medicine2022

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non-small cell lung cancer.

Jie Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.